The European CAR-T Cell Therapy Industry is Expected to Reach $1.9 Billion by 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Europe CAR-T Cell Therapy Market Size, Trends & Growth Opportunity, By Type, By Application, By End-user By country and Forecast till 2027.” report has been added to ResearchAndMarkets.com’s offering. The Europe CAR-T Cell Therapy market was valued at USD 396.21 Mn in 2021 which expected to reach USD 1,904.40 Mn by 2027 at … [Read more…]

Magellan Health Opens 24-hour Crisis Line for Individuals Impacted by the School Shooting in St. Louis, Missouri

Consultation and resources available at no cost to local community FRISCO, Texas–(BUSINESS WIRE)–Magellan Health, Inc. today announced that it has opened a complimentary 24-hour crisis line for individuals impacted by the high school shooting that occurred in St. Louis, Missouri on Monday. The toll-free number to access free, confidential consultation services is 1-800-327-7451. Magellan confidential … [Read more…]

Bayer’s KERENDIA® (finerenone) Recommended as Part of Comprehensive Treatment Strategy for Chronic Kidney Disease Associated With Type 2 Diabetes in Newly Published Clinical Recommendations

New guidelines from Kidney Disease: Improving Global Outcomes (KDIGO) and a consensus report jointly issued from KDIGO and the American Diabetes Association (ADA) include KERENDIA as part of a comprehensive treatment strategy for patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) who have an estimated glomerular filtration rate of >25 mL/min/1.73 … [Read more…]

Shamp Silk and Bell Law Firm Secure $75M in Medical Malpractice Trial for Georgia Man with “Locked-in Syndrome”

Healthcare providers Dr. Matthew Womack and Dr. James Waldschmidt held accountable for negligence ATLANTA–(BUSINESS WIRE)–A Fulton County jury ruled in favor of a Georgia man after a stroke and subsequent medical negligence left him with “locked-in syndrome,” cognitively aware but unable to move any part of his body other than his eyes. Plaintiff Jonathan Buckelew … [Read more…]

Call for Presentations Open for Robotics Summit & Expo and the Healthcare Robotics Engineering Forum

The international technical design and development event for robotics and intelligent systems seeks compelling speakers for each of the tracks CLEVELAND–(BUSINESS WIRE)–WTWH Media invites you to submit a session abstract to be considered for presentation at the Robotics Summit & Expo or the Healthcare Robotics Engineering Forum (HREF), being held May 10-11, 2023 at the … [Read more…]

Urovant Sciences Announces Publication of Pharmacokinetic Data on GEMTESA® (Vibegron 75mg) Administered as an Intact or Crushed Tablet

A new peer-reviewed journal paper suggests that crushing GEMTESA (vibegron) 75-mg and taking it with applesauce may be an appropriate option for people with overactive bladder (OAB) and concommitant swallowing difficulties. Results from this Phase 1 study show that vibegron can be crushed and mixed with applesauce with no clinically meaningful change to pharmacokinetic (PK) … [Read more…]

MarinHealth Selects Eugene Lewis as Chief Human Resources Officer

Former executive director of human resources and interim chief human resources officer succeeds newly retired leader, Linda Lang GREENBRAE, Calif.–(BUSINESS WIRE)–MarinHealth today announced the selection and promotion of its interim chief human resources officer, Eugene Lewis, who will fill the role of chief human resources officer. Lewis succeeds Linda Lang JD, a former senior leader … [Read more…]

Aurinia Pharmaceuticals Announces Presentations at American Society of Nephrology (ASN) Kidney Week 2022

VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the trajectory of autoimmune disease, today announced that data from multiple studies of LUPKYNIS® (voclosporin) will be presented at the American Society of Nephrology (ASN) Kidney Week 2022, taking place November 3-6 in Orlando, Florida. … [Read more…]

The Worldwide Efficacy Testing Industry is Expected to Reach $511.6 Million by 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Efficacy Testing Market Share, Size, Trends, Industry Analysis Report, By Service Type, By Application, By Region, Segment Forecast, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global Efficacy Testing market size is expected to reach USD 511.64 million by 2030 according to a new study. The report gives a detailed … [Read more…]

Valbiotis Will Present Significant Preclinical Results for Its Active Substance TOTUM•448 Against Fatty Liver Diseases (NAFL and NASH), at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)

TOTUM•448 is an innovative plant-based patented active substance developed by Valbiotis, a young French SME, to counteract the development of metabolic liver diseases (NAFL and NASH1). In two preclinical models that mimic the development of fatty liver disease in humans, two studies demonstrate the broad efficacy of TOTUM•448 on the key mechanisms of these diseases, … [Read more…]